Spark Therapeutics (ONCE) Misses Q3 EPS by 22c

Spark Therapeutics (NASDAQ: ONCE) reported Q3 EPS of ($0.70), $0.22 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $4.43 million.

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c